Asha Poorna Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 14-12-2024
- Paid Up Capital ₹ 2.00 M
as on 14-12-2024
- Company Age 36 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.17 M
as on 14-12-2024
- Revenue -14.95%
(FY 2022)
- Profit 136.74%
(FY 2022)
- Ebitda -9342.29%
(FY 2022)
- Net Worth 1.07%
(FY 2022)
- Total Assets 46.42%
(FY 2022)
About Asha Poorna Pharmaceutical
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.17 M.
Shailendra Chauhan and Asha Chauhan serve as directors at the Company.
- CIN/LLPIN
U24231UP1988PTC010038
- Company No.
010038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Asha Poorna Pharmaceutical Private Limited offer?
Asha Poorna Pharmaceutical Private Limited offers a wide range of products and services, including Coir and Agro Products, Psyllium Husk, Herbs,Sticks and Roots.
Who are the key members and board of directors at Asha Poorna Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailendra Chauhan  | Director | 16-Sep-1988 | Current |
| Asha Chauhan | Director | 16-Sep-1988 | Current |
Financial Performance of Asha Poorna Pharmaceutical.
Asha Poorna Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.95% decrease. The company also saw a substantial improvement in profitability, with a 136.74% increase in profit. The company's net worth moved up by a moderate rise of 1.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asha Poorna Pharmaceutical?
In 2019, Asha Poorna Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 10 Nov 2009 | ₹1.00 M | Open |
Punjab National Bank Creation Date: 15 Mar 2005 | ₹0.17 M | Open |
Punjab National Bank Creation Date: 07 Aug 2003 | ₹2.50 M | Open |
How Many Employees Work at Asha Poorna Pharmaceutical?
Unlock and access historical data on people associated with Asha Poorna Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asha Poorna Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asha Poorna Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
